Acyclovir: Pharmacology and Clinical Experience

Archives of Internal Medicine

Volumn 144, Issue 6, 1984, Pages 1241-1246

  Laskin, Oscar L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ACICLOVIR; CEPHALOSPORIN DERIVATIVE; METHOTREXATE; PENICILLIN DERIVATIVE; PROBENECID;

ADVERSE DRUG REACTION; CHICKENPOX; DOSE KIDNEY FUNCTION RELATION; DRUG ELIMINATION; DRUG THERAPY; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES ZOSTER; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KERATOCONJUNCTIVITIS; KIDNEY; NEPHROTOXICITY; PERIPHERAL VASCULAR SYSTEM; PHARMACOLOGY; PHLEBITIS; PROPHYLAXIS; REVIEW; THERAPY;

ACYCLOVIR; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMAN; IMMUNOSUPPRESSION; KINETICS; SUPPORT, NON-U.S. GOV'T;

EID: 0021280176     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1984.00350180181025     Document Type: Article

References (28)

1. Balfour HH, Bean B, Laskin OL, et al: Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 1983;308: 1448-1453.
2. Bean B, Braun C, Balfour HH: Acyclovir therapy for acute herpes zoster. Lancet 1982;2:118-121.
3. Blum MR, Liao SHT, de Miranda P: Overview of acyclovir pharmacokinetic disposition in adults and children. Am J Med 1982;73(1A):186-192.
4. Bryson YJ, Dillon M, Lovett M, et al: Treatment of the first episodes of genital herpes simplex virus infection with oral acyclovir: A randomized double-blind controlled trial in normal subjects. N Engl J Med 1983;308: 916-921.
5. Burns WH, Saral R, Santos GW, et al: Isolation and characterization of resistant herpes simplex virus after acyclovir therapy. Lancet 1982;1: 421-423.
6. Chou S, Gallagher JG, Merigan TC: Controlled clinical trial of intravenous acyclovir in heart transplant patients with mucocutaneous herpes simplex infections. Lancet 1981;1:1392-1394.
7. Corey L, Nahmias AJ, Guinan ME, et al: A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med 1982;306:1313-1319.
8. Crumpacker CS, Schnipper LE, Marlowe SI, et al: Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med 1982;306:343-346.
9. De Miranda P, Good SS, Laskin OL, et al: Disposition of intravenous radioactive acyclovir. Clin Pharmacol Ther 1981;30:662-672.
10. Elion GB: Mechanism of action and selectivity of acyclovir. Am J Med 1982;73(1a):7-13.
11. Elion GB, Furman PA, Fyfe JA, et al: Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc Natl Acad Sci USA 1977;74:5716-5720.
12. Jones BR, Coster DJ, Fison PN, et al: Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet 1979;1: 243-244.
13. Keeney RE, Kirk LE, Bridgen D: Acyclovir tolerance in humans. Am J Med 1982;73(1A):176-181.
14. Laskin OL: Clinical pharmacokinetics of acyclovir. Clin Pharmacokinet 1983;8:187-201.
15. Laskin OL, de Miranda P, King DH, et al: Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans. Antimicrob Agents Chemother 1982;21:804-807.
16. Laskin OL, Longstreth JA, Saral R, et al: Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans. Antimicrob Agents Chemother 1982;21:393-398.
17. Laskin OL, Longstreth JA, Whelton A, et al: Effect of renal failure on the pharmacokinetics of acyclovir. Am J Med 1982;73(1A):197-201.
18. Laskin OL, Longstreth JA, Whelton A, et al: Acyclovir kinetics in end-stage renal disease. Clin Pharmacol Ther 1982;31:594-601.
19. Laskin OL, Saral R, Burns WH, et al: Acyclovir concentrations and tolerance during repetitive administration for 18 days. Am J Med 1982;73(1A):221-224.
20. Meyers JD, Wade JC, Mitchell CD, et al: Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 1982;73(1A):229-235.
21. Mindel A, Adler MW, Sutherland S, et al: Intravenous acyclovir treatment for primary genital herpes. Lancet 1982;1:697-700.
22. Peterslund NA, Seyer-Hansen K, Ipsen J, et al: Acyclovir in herpes zoster. Lancet 1981;2:827-830.
23. Reichman RC, Badger GJ, Guinan ME, et al: Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: A controlled trial. J Infect Dis 1983;147:336-340.
24. Saral R, Burns WH, Laskin OL, et al: Acyclovir prophylaxis of herpes simplex virus infections: A randomized double-blind controlled trial in bone marrow transplant recipients. N Engl J Med 1981;305:63-67.
25. Schaeffer HJ, Beauchamp L, de Miranda P, et al: 9-(2-hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature 1978;272:583-585.
26. Sibrack CD, Gutman LT, Wilfert CM, et al: Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis 1982;146:673-682.
27. Wade JC, Hintz M, McGuffin RW, et al: Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med 1982;73(1A):249-256.
28. Whitley R, Barton N, Collins E, et al: Mucocutaneous herpes simplex virus infections in immunocompromised patients: A model for evaluation of topical antiviral agents. Am J Med 1982;73(1A):236-240.